PIMS-E is a pharmaceutical company based in Roden with its own development and production facilities. PIMS-E was founded as a result of a collaboration between the departments of Pharmaceutical Technology and Biopharmacy at the University of Groningen by Professor Dr. H. W. Frijlink. This unique collaboration provides PIMS-E with an experienced, enthusiastic and highly motivated team of researchers, pharmacists, pharmacy assistants, pharmaceutical experts, QA/RA professionals and product process developers.
PIMS-E used inhalation technology to develop an alternative to the Epipen™, Cyclops® (dry-powder inhalation): which administers adrenaline to people experiencing a life-threatening allergic reaction to bee or wasp stings or to medicines or food. The substance takes effect almost instantly through powder inhalation, has a long shelf-life (it does not need to be stored in the fridge) and there is no further need for injections.
Carduso Capital participates in technology companies that are preferably based on the know-how represented in and originating from the Groningen science cluster in and around the University of Groningen (RUG) and the ...
These cookies make sure the website functions properly. These cookies also provide us to anonymously monitor website statistics. Because these cookies are essential for the website, you can not disable them without compromising the functionality of the website.
These cookies collect data that we use to understand how our website is used and perceived. These cookies also help us to optimize the website for the best user experience.
These cookies allow ad-networks to monitor your online behaviour so they can display relevant ads based on your interest and online behaviour. These cookies also prevent the same ads from being displayed over and over.
